Advertisement

Topics

Express Scripts shuts out 64 branded drugs from 2018 formulary

05:50 EDT 31 Jul 2017 | BioPharmaDive

Among the drugs excluded from the PBM's preferred list were Amgen's Neupogen, Eli Lilly's Forteo and Synergy Pharmaceuticals' newly approved Trulance.

Original Article: Express Scripts shuts out 64 branded drugs from 2018 formulary

NEXT ARTICLE

More From BioPortfolio on "Express Scripts shuts out 64 branded drugs from 2018 formulary"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...